Inicio › Cáncer de pulmón › Illinois › Waukegan
Ensayos clínicos de Cáncer de pulmón en Waukegan, IL
16 estudios para Cáncer de pulmón buscan participantes en centros de Waukegan y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ReclutandoFase 3
- AMG Libertyville - Oncology, Libertyville · A 8 mi de distancia
- Condell Memorial Hospital, Libertyville · A 8 mi de distancia
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- AMG Libertyville - Oncology, Libertyville · A 8 mi de distancia
- Condell Memorial Hospital, Libertyville · A 8 mi de distancia
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ReclutandoFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · A 7 mi de distancia
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · A 10 mi de distancia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- AMG Libertyville - Oncology, Libertyville · A 8 mi de distancia
- Condell Memorial Hospital, Libertyville · A 8 mi de distancia
Empathic Communication Skills (ECS) Training
ReclutandoSe aceptan voluntarios sanos
- Advocate Health Care Network, Libertyville · A 8 mi de distancia
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · A 7 mi de distancia
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · A 10 mi de distancia
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ReclutandoFase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · A 8 mi de distancia
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- City of Hope - Chicago, Zion · A 6 mi de distancia
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ReclutandoFase 3
- City of Hope® Cancer Center Chicago, Zion · A 6 mi de distancia
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutandoFase 3
- Midwestern Regional Medical Center, Zion · A 6 mi de distancia
- AMG Libertyville - Oncology, Libertyville · A 8 mi de distancia
- Condell Memorial Hospital, Libertyville · A 8 mi de distancia
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Reclutando
- Captain James A. Lovell Federal Health Care Center, North Chicago · A 3 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · A 7 mi de distancia
- AMG Libertyville - Oncology, Libertyville · A 8 mi de distancia
- Condell Memorial Hospital, Libertyville · A 8 mi de distancia
- y 1 más
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · A 7 mi de distancia
- AMG Libertyville - Oncology, Libertyville · A 8 mi de distancia
- Condell Memorial Hospital, Libertyville · A 8 mi de distancia
- y 1 más
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · A 7 mi de distancia
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · A 10 mi de distancia
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
ReclutandoFase 2
- City of Hope at Chicago, Zion · A 6 mi de distancia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
ReclutandoEstudio observacional
- AMG Libertyville - Oncology, Libertyville · A 8 mi de distancia
- Condell Memorial Hospital, Libertyville · A 8 mi de distancia
Más información sobre Cáncer de pulmón en MedlinePlus
Ensayos de Cáncer de pulmón en otras ciudades
- Houston, TX78 estudios
- Boston, MA62 estudios
- New York City, NY60 estudios
- Los Angeles, CA45 estudios
- Arlington, VA41 estudios
- Washington, DC41 estudios
- Chicago, IL41 estudios
- Nashville, TN40 estudios
- Baltimore, MD40 estudios
- St. Louis, MO39 estudios
- Columbus, OH37 estudios
- Philadelphia, PA36 estudios
Otros estudios en Waukegan
- Cáncer de pulmón de células no pequeñas16 estudios
- Cáncer de seno12 estudios
- Colitis ulcerativa7 estudios
- Cáncer de riñón (carcinoma de células renales)7 estudios
- Cáncer de ovario6 estudios
- Cáncer metastásico6 estudios
- Carcinoma de células escamosas de cabeza y cuello6 estudios
- Cáncer del colon y del recto6 estudios
- Cáncer de próstata6 estudios
- Melanoma5 estudios
- Leucemia mielógena aguda5 estudios
- Enfermedad de Crohn5 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.